IGF1R and breast carcinoma: Specifically, MEMO1 was found to control estrogen receptor α (ERα) sub-cellular localization, phosphorylation, and function downstream of ErbB2/ER or IGFIR/ER thereby activating MAPK and PI3K signaling pathways that promoted breast cancer cell migration and/or proliferation [77,78].